A likelihood-based index of protein-protein binding affinities with application to influenza HA escape from antibodies

Molecular Biology and Evolution

Volumn 24, Issue 8, 2007, Pages 1627-1638

  Watabe, Teruaki ^a   Kishino, Hirohisa ^b   De Oliveira Martins, Leonardo ^b   Kitazoe, Yasuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Affinity of complex; Antigenic drift; Functional redundancy; Influenza virus; Protein structure

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; IMMUNE SYSTEM; MOLECULAR EVOLUTION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ALGORITHMS; AMINO ACIDS; ANTIBODIES, MONOCLONAL; ANTIGENIC VARIATION; BETA-LACTAMASES; BINDING SITES, ANTIBODY; CELL LINE; CRYSTALLOGRAPHY, X-RAY; EPITOPES; GENE EXPRESSION REGULATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS; LIKELIHOOD FUNCTIONS; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, VIRUS;

ORTHOMYXOVIRIDAE;

EID: 34547808856     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msm079     Document Type: Article

References (35)

1. Afonnikov DA, Oshchepkov DY, Kolchanov NA. 2001. Detection of conserved physico-chemical characteristics of proteins by analyzing clusters of positions with co-ordinated substitutions. Bioinformatics. 17:1035-1046.
2. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology. 294:70-74.
3. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bösecke P, Wharton SA, Skehel JJ, Knossow M. 1995. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature. 376:92-94.
4. Bush RM, Fitch WM, Bender CA, Cox NJ. 1999. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol. 16:1457-1465.
5. Cox NJ, Bender CA. 1995. The molecular epidemiology of influenza viruses. Semin Virol. 6:359-370.
6. Dang W, Nikolajczyk BS, Sen R. 1998. Exploring functional redundancy in the immunoglobulin μ heavy-chain gene enhancer. Mol Cell Biol. 18:6870-6878.
7. Dimitrov DS. 2004. Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol. 2:109-122.
8. Felsenstein J. 2005. PHYLIP (Phylogeny inference package) version 3.6. Department of Genome Sciences, University of Washington, Seattle.
9. Fields BA, Goldbaum FA, Ysern X, Poljak RJ, Mariuzza RA. 1995. Molecular basis of antigen mimicry by an anti-idiotope. Nature. 374:739-742.
10. Fleury D, Barrère B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol. 6:530-534.
11. Fleury D, Daniels RS, Skehel JJ, Knossow M, Bizebard T. 2000. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins. 40:572-578.
12. Gubareva LV, Novikov DV, Hayden FG. 2002. Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. J Infect Dis. 186:1575-1581.
13. Ha Y, Stevens DJ, Skehel JJ, Wiley DC. 2003. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology. 309:209-218.
14. Hobohm U, Sander C. 1994. Enlarged representative set of protein structures. Protein Sci. 3:522-524.
15. Holmes KV. 2005. Adaptation of SARS coronavirus to humans. Science. 309:1822-1823.
16. Jenwitheesuk E, Samudrala R. 2003. Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations. BMC Struct Biol. 3:2.
17. Jones DT, Taylor WR, Thornton JM. 1992. A new approach to protein fold recognition. Nature. 358:86-89.
18. Jones DT. 1999. GenTHREADER: an efficient and reliable protein fold recognition method for genomic sequences. J Mol Biol. 287:797-815.
19. Knossow M, Gaudier M, Douglas A, Barrère B, Bizebard T, Barbey C, Gigant B, Skehel JJ. 2002. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology. 302:294-298.
20. Li W, Zhang C, Sui J. (16 co-authors). 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24:1634-1643.
21. Lim D, Park HU, LDe Castro, Kang SG, Lee HS, Jensen S, Lee KJ, Strynadka NCJ. 2001. Crystal structure and kinetic analysis of β-lactamase inhibitor protein-II in complex with TEM-1 β-lactamase. Nat Struct Biol. 8:848-852.
22. Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG. 2004. Influenza: emergence and control. J Virol. 78:8951-8959.
23. Nakajima K, Nobusawa E, Nagy A, Nakajima S. 2005. Accumulation of amino acid substitutions promotes irreversible structural changes in the hemagglutinin of human influenza AH3 virus during evolution. J Virol. 79:6472-6477.
24. Naoi Y, Chong KT, Yoshimatsu K, Miyazaki G, Tame JRH, Park SY, Adachi S, Morimoto H. 2001. The functional similarity and structural diversity of human and cartilaginous fish hemoglobins. J Mol Biol. 307:259-270.
25. Padlan EA, Abergle C, Tipper JP. 1995. Identification of specificity-determining residues in antibodies. FASEB J. 9:133-139.
26. Robinson DM, Jones DT, Kishino H, Goldman N, Thorne JL. 2003. Protein Evolution with dependence among codons due to tertiary structure. Mol Biol Evol. 20:1692-1704.
27. Simons KT, Bonneau R, Ruczinski I, Baker D. 1999a. Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins. 37(Suppl. 3):171-176.
28. Simons KT, Ruczinski I, Kooperberg C, Fox BA, Bystroff C, Baker D. 1999b. Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins. Proteins. 34:82-95.
29. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science. 305:371-376.
30. Swofford DL. 2003. PAUP* version 4.0: Phylogenetic analysis using parsimony (*and other methods). Sunderland (MA): Sinauer Associates.
31. Vilches C, Parham P. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 20:217-251.
32. Watabe T, Kishino H, Okuhara Y, Kitazoe Y. 2006. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host. Genetics. 172:1385-1396.
33. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev. 56:152-179.
34. Webster RG. 2000. Immunity to influenza in the elderly. Vaccine. 18:1686-1689.
35. Zhang Z, Palzkill T. 2003. Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 β-lactamase with β-lactamase inhibitory protein. J Biol Chem. 278:45706-45712.